Filing metadata

Accession number
0001326389-22-000013
Form type
Form 4
Filer
Calidi Biotherapeutics, Inc.
CIK
CIK 1855485
Filed
Oct 21, 2022
Reporting period
Oct 19, 2022
Description
Insider transaction

Explore SEC Filings Hub